PPD

Views & Analysis

A collaborative approach to greater diversity in clinical tr...

The need for diversity in clinical trial populations has been a topic of discussion across regulators and the industry in general for decades.

News

FDA panel backs Sage’s novel antidepressant but turns down A...

Sage’s Zulresso (brexanolone) is on course for approval for postnatal depression in the US after a positive vote from an FDA advisory committee at its meeting last week, but the same panel had bad

News

BioMarin snaps up Alesta's lead asset for $275M

BioMarin will acquire Alesta's experimental therapy for rare bone disease hypophosphatasia for up to $490 million.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks